Guangdong Biolight Meditech Co., Ltd. (300246.SZ)
CNY 7.18
(3.01%)
CNY 7.18
(3.01%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 307.77 Million CNY | 12.15% |
| 2022 | 274.42 Million CNY | 28.64% |
| 2021 | 213.32 Million CNY | 31.51% |
| 2020 | 162.21 Million CNY | 121.68% |
| 2019 | 73.17 Million CNY | 4.73% |
| 2018 | 69.86 Million CNY | 0.0% |
| 2017 | - CNY | -100.0% |
| 2016 | 1.00 CNY | 0.0% |
| 2015 | - CNY | 100.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 421.71 Million CNY | 15.93% |
| 2024 Q3 | 395.79 Million CNY | -0.81% |
| 2024 Q1 | 344.17 Million CNY | 21.12% |
| 2023 Q3 | 298.69 Million CNY | -7.63% |
| 2023 FY | 307.77 Million CNY | 12.15% |
| 2023 Q2 | 323.36 Million CNY | 1.79% |
| 2023 Q4 | 307.77 Million CNY | 3.04% |
| 2023 Q1 | 317.67 Million CNY | 15.76% |
| 2022 Q3 | 243.01 Million CNY | -4.81% |
| 2022 Q2 | 255.29 Million CNY | 17.04% |
| 2022 Q1 | 218.12 Million CNY | 2.25% |
| 2022 FY | 274.42 Million CNY | 28.64% |
| 2022 Q4 | 274.42 Million CNY | 12.93% |
| 2021 Q1 | 165.08 Million CNY | 1.77% |
| 2021 FY | 213.32 Million CNY | 31.51% |
| 2021 Q4 | 213.32 Million CNY | 5.58% |
| 2021 Q3 | 202.05 Million CNY | 20.31% |
| 2021 Q2 | 167.94 Million CNY | 1.73% |
| 2020 Q1 | 72.63 Million CNY | -0.74% |
| 2020 Q3 | 207.87 Million CNY | 328.05% |
| 2020 Q4 | 162.21 Million CNY | -21.97% |
| 2020 FY | 162.21 Million CNY | 121.68% |
| 2020 Q2 | 48.56 Million CNY | -33.14% |
| 2019 Q1 | 68.12 Million CNY | -2.5% |
| 2019 FY | 73.17 Million CNY | 4.73% |
| 2019 Q4 | 73.17 Million CNY | -2.04% |
| 2019 Q3 | 74.69 Million CNY | 7.2% |
| 2019 Q2 | 69.68 Million CNY | 2.3% |
| 2018 Q3 | 64.26 Million CNY | 37.22% |
| 2018 Q4 | 69.86 Million CNY | 8.72% |
| 2018 Q2 | 46.83 Million CNY | -0.99% |
| 2018 FY | 69.86 Million CNY | 0.0% |
| 2018 Q1 | 47.3 Million CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 FY | - CNY | -100.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 FY | 1.00 CNY | 0.0% |
| 2016 Q4 | 1.00 CNY | 0.0% |
| 2016 Q3 | - CNY | 100.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 Q1 | - CNY | 100.0% |
| 2015 FY | - CNY | 100.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2013 Q3 | - CNY | 0.0% |
| 2013 Q2 | - CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2012 Q1 | - CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q2 | - CNY | 0.0% |
| 2011 Q3 | - CNY | 0.0% |
| 2011 Q2 | - CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| 2011 Q4 | - CNY | 0.0% |
| 2010 FY | - CNY | 0.0% |
| 2010 Q4 | - CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |